CONSENT OF KPMG LLP
Published on
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Obalon Therapeutics, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
| /s/ KPMG LLP |
San Diego, California
September 23, 2016